Association of genetic variants with rapid fibrosis: Progression after liver transplantation for hepatitis C

Transplantation

Volumn 97, Issue 10, 2014, Pages 1072-1078

  Layden, Jennifer E ^a   Tayo, Bamidele O ^a   Cotler, Scott J ^a   Clark, Nina M ^a   Baraoidan, Kristine ^b   Friedman, Scott L ^c   Cooper, Richard S ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Candidate gene study; Hepatitis C virus; Liver transplantation

Indexed keywords

INTERLEUKIN 28B;

ADULT; ALLELE; ARTICLE; DISEASE COURSE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HEPATITIS C; HUMAN; IMMUNE RESPONSE; INTERLEUKIN 28B GENE; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; DISEASE PROGRESSION; DNA; FEMALE; FOLLOW-UP STUDIES; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HEPATITIS C, CHRONIC; HUMANS; INTERLEUKINS; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 84901288942     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000440953.06886.a3     Document Type: Article

References (44)

1. Charlton M. Hepatitis C infection in liver transplantation. Am J Transplant 2001; 1: 197.
2. Forman LM, Lewis JD, Berlin JA, et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889.
3. Testa G, Crippin JS, Netto GJ, et al. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl 2000; 6: 553.
4. Berenguer M, Prieto M, Rayón JM, et al. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 2000; 32(4 Pt 1): 852.
5. Berenguer M, Crippin J, Gish R, et al. A model to predict severe HCVrelated disease following liver transplantation. Hepatology 2003; 38: 34.
6. Ananthakrishnan AN, Saeian K. Racial differences in liver transplantation outcomes in the MELD era. Am J Gastroenterol 2008; 103: 901.
7. Berenguer M. Host and donor risk factors before and after liver transplantation that impact HCV recurrence. Liver Transpl 2003; 9: S44.
8. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006; 6: 783.
9. Gane EJ, Naoumov NV, Qian KP, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 1996; 110: 167.
10. Layden JE, Cotler SJ, Grim SA, et al. Impact of donor and recipient race on survival after hepatitis C-related liver transplantation. Transplantation 2012; 93: 444.
11. Neff GW, Kemmer N, Kaiser T, et al. Outcomes in adult and pediatric liver transplantation among various ethnic groups. Transplant Proc 2007; 39: 3204.
12. Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: a cohort study. Lancet 2002; 359: 287.
13. Pang PS, Kamal A, Glenn JS. The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis C. Liver Transpl 2009; 15: 1126.
14. Saxena V, Lai JC, O'Leary JG, et al. Recipient-donor race mismatch for African-American liver transplant patients with chronic hepatitis C. Liver Transpl 2012; 18: 524.
15. Layden JE, Cotler S, Brown KA, et al. Racial differences in fibrosis progression after HCV-related liver transplantation. Transplantation 2012; 94: 178.
16. Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461: 798.
17. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461: 399.
18. Huang H, Shiffman ML, Friedman S, et al. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology 2007; 46: 297.
19. Guo J, Hong F, Loke J, et al. A DDX5 S480A polymorphism is associated with increased transcription of fibrogenic genes in hepatic stellate cells. J Biol Chem 2010; 285: 5428.
20. Huang H, Shiffman ML, Cheung RC, et al. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology 2006; 130: 1679.
21. Valenti L, Rumi M, Galmozzi E, et al. Patatin-like phospholipase domain-containing 3 I148Mpolymorphism, steatosis, and liver damage in chronic hepatitis C. Hepatology 2011; 53: 791.
22. Trepo E, Pradat P, Potthoff A, et al. Impact of patatin-like phospholipase-3 (rs738409 C9G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Hepatology 2011; 54: 60.
23. Petta S, Grimaudo S, Camma C, et al. IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with nonalcoholic fatty liver disease. J Hepatol 2012; 56: 1356.
24. Handy JA, Saxena NK, Fu P, et al. Adiponectin activation of AMPK disrupts leptin-mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS-3). J Cell Biochem 2010; 110: 1195.
25. Charlton MR, Thompson A, Veldt BJ, et al. Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection. Hepatology 2011; 53: 317.
26. Lange CM, Moradpour D, Doehring A, et al. Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection. J Hepatol 2011; 55: 322.
27. Eurich D, Boas-Knoop S, Ruehl M, et al. Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation. Liver Transpl 2011; 17: 289.
28. Duarte-Rojo A, Veldt BJ, Goldstein DD, et al. The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables. Transplantation 2012; 94: 197.
29. Cisneros E, Baños I, Citores MJ, et al. Increased risk of severe hepatitis C virus recurrence after liver transplantation in patients with a T allele of IL28B rs12979860. Transplantation 2012; 94: 275.
30. do O NT, Eurich D, Schmitz P, et al. A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection. Liver Transpl 2012; 18: 298.
31. do O NT, Eurich D, Trautwein C, et al. The common I148M variant of PNPLA3 does not predict fibrosis progression after liver transplantation for hepatitis C. Hepatology 2011; 54: 1483.
32. Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003; 4: 69.
33. Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003; 4: 63.
34. Shuai K, Liu B. Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 2003; 3: 900.
35. Shao RX, Zhang L, Peng LF, et al. Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner. J Virol 2010; 84: 6060.
36. Ye L, Wang X, Metzger DS, et al. Upregulation of SOCS-3 and PIAS-3 impairs IL-12-mediated interferon-gamma response in CD56 T cells in HCV-infected heroin users. PLoS One 2010; 5: e9602.
37. Kim KA, Lin W, Tai AW, et al. Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/ HIV infection. J Hepatol 2009; 50: 705.
38. Schallus T, Jaeckh C, Fehér K, et al. Malectin: a novel carbohydratebinding protein of the endoplasmic reticulum and a candidate player in the early steps of protein N-glycosylation.Mol Biol Cell 2008; 19: 3404.
39. Knodell RG, Farleigh RM. Chronic active hepatitis: a plea for conservative management. Geriatrics 1981; 36: 111.
40. Valenti L, Fargion S. Patatin-like phospholipase domain containing-3 Ile148Met and fibrosis progression after liver transplantation. Hepatology 2011; 54: 1484.
41. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263.
42. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995; 29: 311.
43. Hudson RR, Kaplan NL. Statistical properties of the number of recombination events in the history of a sample of DNA sequences. Genetics 1985; 111: 147.
44. Wang N, Akey JM, Zhang K, et al. Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation. Am J Hum Genet 2002; 71: 1227.